4-[benzyl(ethyl)sulfamoyl]-N-[3-(dimethylamino)propyl]-N-(4-methoxy-1,3-benzothiazol-2-yl)benzamide;hydrochloride

C29H35ClN4O4S2 — CID 44930301

IUPAC4-[benzyl(ethyl)sulfamoyl]-N-[3-(dimethylamino)propyl]-N-(4-methoxy-1,3-benzothiazol-2-yl)benzamide;hydrochloride
SMILESCCN(Cc1ccccc1)S(=O)(=O)c1ccc(C(=O)N(CCCN(C)C)c2nc3c(OC)cccc3s2)cc1.Cl
InChIInChI=1S/C29H34N4O4S2.ClH/c1-5-32(21-22-11-7-6-8-12-22)39(35,36)24-17-15-23(16-18-24)28(34)33(20-10-19-31(2)3)29-30-27-25(37-4)13-9-14-26(27)38-29;/h6-9,11-18H,5,10,19-21H2,1-4H3;1H
InChIKeyVOXNVMLATGVYBJ-UHFFFAOYSA-N
MW603.21 g/mol
LogP5.54
Rot. Bonds12

About 4-[benzyl(ethyl)sulfamoyl]-N-[3-(dimethylamino)propyl]-N-(4-methoxy-1,3-benzothiazol-2-yl)benzamide;hydrochloride

4-[benzyl(ethyl)sulfamoyl]-N-[3-(dimethylamino)propyl]-N-(4-methoxy-1,3-benzothiazol-2-yl)benzamide;hydrochloride (PubChem CID 44930301) has the molecular formula C29H35ClN4O4S2 and a molecular weight of 603.21 g/mol. Its IUPAC name is 4-[benzyl(ethyl)sulfamoyl]-N-[3-(dimethylamino)propyl]-N-(4-methoxy-1,3-benzothiazol-2-yl)benzamide;hydrochloride.

Molecular Properties

Compound Name4-[benzyl(ethyl)sulfamoyl]-N-[3-(dimethylamino)propyl]-N-(4-methoxy-1,3-benzothiazol-2-yl)benzamide;hydrochloride
PubChem CID44930301
Molecular FormulaC29H35ClN4O4S2
Molecular Weight603.21 g/mol
Exact Mass602.18
IUPAC Name4-[benzyl(ethyl)sulfamoyl]-N-[3-(dimethylamino)propyl]-N-(4-methoxy-1,3-benzothiazol-2-yl)benzamide;hydrochloride
SMILESCCN(Cc1ccccc1)S(=O)(=O)c1ccc(C(=O)N(CCCN(C)C)c2nc3c(OC)cccc3s2)cc1.Cl
InChIInChI=1S/C29H34N4O4S2.ClH/c1-5-32(21-22-11-7-6-8-12-22)39(35,36)24-17-15-23(16-18-24)28(34)33(20-10-19-31(2)3)29-30-27-25(37-4)13-9-14-26(27)38-29;/h6-9,11-18H,5,10,19-21H2,1-4H3;1H
InChIKeyVOXNVMLATGVYBJ-UHFFFAOYSA-N
XLogP5.54
TPSA83.05 Ų
H-Bond Donors
H-Bond Acceptors7
Rotatable Bonds12
Heavy Atoms40
Complexity

Lipinski Rule of Five

2 violations

RuleValue
MW ≤ 500603.21
LogP ≤ 55.54
H-Bond Donors ≤ 50
H-Bond Acceptors ≤ 107

Analyze 4-[benzyl(ethyl)sulfamoyl]-N-[3-(dimethylamino)propyl]-N-(4-methoxy-1,3-benzothiazol-2-yl)benzamide;hydrochloride with MolForge

Explore ADMET properties, 3D molecular structure, drug-likeness score, and discover similar compounds using our AI-powered platform.

Launch Full Analysis

Frequently Asked Questions

What is the IUPAC name of 4-[benzyl(ethyl)sulfamoyl]-N-[3-(dimethylamino)propyl]-N-(4-methoxy-1,3-benzothiazol-2-yl)benzamide;hydrochloride?
The IUPAC name of 4-[benzyl(ethyl)sulfamoyl]-N-[3-(dimethylamino)propyl]-N-(4-methoxy-1,3-benzothiazol-2-yl)benzamide;hydrochloride (CID 44930301) is 4-[benzyl(ethyl)sulfamoyl]-N-[3-(dimethylamino)propyl]-N-(4-methoxy-1,3-benzothiazol-2-yl)benzamide;hydrochloride.
What is the SMILES notation for 4-[benzyl(ethyl)sulfamoyl]-N-[3-(dimethylamino)propyl]-N-(4-methoxy-1,3-benzothiazol-2-yl)benzamide;hydrochloride?
The canonical SMILES for 4-[benzyl(ethyl)sulfamoyl]-N-[3-(dimethylamino)propyl]-N-(4-methoxy-1,3-benzothiazol-2-yl)benzamide;hydrochloride is CCN(Cc1ccccc1)S(=O)(=O)c1ccc(C(=O)N(CCCN(C)C)c2nc3c(OC)cccc3s2)cc1.Cl.
What is the InChIKey of 4-[benzyl(ethyl)sulfamoyl]-N-[3-(dimethylamino)propyl]-N-(4-methoxy-1,3-benzothiazol-2-yl)benzamide;hydrochloride?
The InChIKey is VOXNVMLATGVYBJ-UHFFFAOYSA-N. The full InChI is InChI=1S/C29H34N4O4S2.ClH/c1-5-32(21-22-11-7-6-8-12-22)39(35,36)24-17-15-23(16-18-24)28(34)33(20-10-19-31(2)3)29-30-27-25(37-4)13-9-14-26(27)38-29;/h6-9,11-18H,5,10,19-21H2,1-4H3;1H.
What are the key properties of 4-[benzyl(ethyl)sulfamoyl]-N-[3-(dimethylamino)propyl]-N-(4-methoxy-1,3-benzothiazol-2-yl)benzamide;hydrochloride?
4-[benzyl(ethyl)sulfamoyl]-N-[3-(dimethylamino)propyl]-N-(4-methoxy-1,3-benzothiazol-2-yl)benzamide;hydrochloride has a molecular weight of 603.21 g/mol, XLogP of 5.54, 12 rotatable bonds, 0 hydrogen bond donors, and 7 hydrogen bond acceptors.
Where does this data come from?
All data for 4-[benzyl(ethyl)sulfamoyl]-N-[3-(dimethylamino)propyl]-N-(4-methoxy-1,3-benzothiazol-2-yl)benzamide;hydrochloride is sourced from PubChem (CID 44930301), the world's largest open chemistry database maintained by the National Library of Medicine (NIH).